NASDAQ · LNSR
Healthcare · Medical - Devices
$6.75
Up+$0.18 (+2.74%)
Updated Oct 5, 2026, 2:12 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · LNSR
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
LNSR closed at $6.75 after 19 trading sessions, down 21.51% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $6.57 | $6.8688 | $6.5501 | $6.75 | 69.84K |
| Oct 1, 2026 | $6.58 | $6.80 | $6.50 | $6.57 | 40.94K |
| Sep 30, 2026 | $6.95 | $6.95 | $6.59 | $6.59 | 35.7K |
| Sep 29, 2026 | $6.85 | $6.95 | $6.78 | $6.90 | 25.85K |
| Sep 28, 2026 | $6.92 | $6.97 | $6.79 | $6.88 | 34.77K |
| Sep 25, 2026 | $7.06 | $7.15 | $6.92 | $6.92 | 22.8K |
| Sep 24, 2026 | $7.15 | $7.17 | $6.98 | $7.075 | 17.63K |
| Sep 23, 2026 | $7.26 | $7.26 | $6.975 | $7.15 | 28.28K |
| Sep 22, 2026 | $7.24 | $7.30 | $7.15 | $7.25 | 29.19K |
| Sep 21, 2026 | $7.06 | $7.25 | $6.99 | $7.21 | 70.45K |
| Sep 18, 2026 | $7.00 | $7.23 | $6.90 | $7.07 | 124.41K |
| Sep 17, 2026 | $7.19 | $7.19 | $6.90 | $7.09 | 58.84K |
| Sep 16, 2026 | $7.50 | $7.77 | $7.08 | $7.08 | 101.28K |
| Sep 15, 2026 | $7.83 | $7.92 | $7.55 | $7.64 | 91.48K |
| Sep 14, 2026 | $7.68 | $7.97 | $7.68 | $7.81 | 64.57K |
| Sep 11, 2026 | $8.12 | $8.18 | $7.60 | $7.60 | 82.34K |
| Sep 10, 2026 | $8.435 | $8.435 | $8.05 | $8.05 | 70.63K |
| Sep 9, 2026 | $8.55 | $8.60 | $8.25 | $8.31 | 68.93K |
| Sep 8, 2026 | $8.58 | $8.7303 | $8.50 | $8.60 | 108.63K |
The latest Smart Investors Daily articles mentioning LNSR.
Company
Market Activity
Research & News
LNSR research
Company profile and research snapshot.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 28, 2026 | LUCID CAPITAL MARKETS | Buy | — |
| Aug 20, 2026 | BTIG | Buy | — |
| Aug 13, 2026 | BTIG | Buy | — |
| Mar 18, 2026 | BTIG | Buy | — |
| Mar 24, 2025 | Lake Street | Hold | — |
No generated briefing is available yet.
Benzinga · Sep 28, 2026
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on LENSAR (NASDAQ:LNSR) with a Buy rating and announces Price Target of $11.
Benzinga · Aug 20, 2026
BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $9 to $10.
Benzinga · Aug 13, 2026
BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $7 to $9.
SeekingAlpha · Aug 13, 2026
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call August 13, 2026 8:30 AM EDTCompany ParticipantsNicholas Curtis - President, CEO & DirectorMichael Rossi -...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LNSR.
